首页> 外文OA文献 >Monitoring circulating epithelial tumour cells (CETC) to gauge therapy: in patients with disease progression after trastuzumab persisting CETC can be eliminated by combined lapatinib treatment

【2h】

Monitoring circulating epithelial tumour cells (CETC) to gauge therapy: in patients with disease progression after trastuzumab persisting CETC can be eliminated by combined lapatinib treatment

机译：监测循环上皮肿瘤细胞（CETC）以评估治疗方法：曲妥珠单抗后疾病进展的患者，通过联合拉帕替尼治疗可以消除持续存在的CETC

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Monitoring circulating epithelial tumour cells (CETC) to gauge therapy: in patients with disease progression after trastuzumab persisting CETC can be eliminated by combined lapatinib treatment. [J] . Camara O, Jorke C, Hammer U, Journal of Cancer Research and Clinical Oncology . 2009,第4期

机译：监测循环上皮肿瘤细胞（CETC）以评估治疗方法：曲妥珠单抗后疾病进展的患者，通过联合拉帕替尼治疗可以消除持续存在的CETC。
2. Monitoring circulating epithelial tumor cells (CETCs) during primary systemic chemotherapy including trastuzumab for early prediction of outcome in patients with Her2eu-positive tumors [J] . M. Gajda1 O. Camara2 S. Oppel3 T. Kroll3 C. J?rke3 S. Krauspe2 U. Hammer3 C. Rabenstein4 M. Untch5 I. B. Runnebaum2 and K. Pachmann3 Annals of Oncology . 2008,第12期

机译：在主要系统化疗期间（包括曲妥珠单抗）监测循环上皮肿瘤细胞（CETC），以早期预测Her2 / neu阳性肿瘤患者的预后
3. 5156 A tool to improve personalized cancer care: measuring the response of circulating epithelial tumour cells (CETC) and tumour stem cell subpopulations to therapy in the individual patient [J] . K.Pachmann, O.Camara, I.B.Runnebaum, European Journal of Cancer Supplements . 2009,第2期

机译：5156一种改善个性化癌症护理的工具：测量循环上皮肿瘤细胞（CETC）和肿瘤干细胞亚群对个别患者治疗的反应
4. Real Time Monitoring of Solid Tumor Progression Using Circulating Stromal Cells in Early and Late Stage Disease [C] . Cha-Mei Tang International Molecular Medicine Tri-Conference. . 2019

机译：早期和晚期疾病中使用循环基质细胞实时监测实体肿瘤进展
5. Second Generation Cardiac Cell Therapy: Combining Cardiac Stem Cells and Circulating Angiogenic Cells for the Treatment of Ischemic Heart Disease. [D] . Latham, Nicholas. 2013

机译：第二代心脏细胞疗法：结合心脏干细胞和循环血管生成细胞治疗缺血性心脏病。
6. Monitoring circulating epithelial tumor cells (CETCs) during primary systemic chemotherapy including trastuzumab for early prediction of outcome in patients with Her2eu-positive tumors [O] . M. Gajda, O. Camara, S. Oppel, -1

机译：在主要系统化疗期间（包括曲妥珠单抗）监测循环上皮肿瘤细胞（CETC）以早期预测Her2 / neu阳性肿瘤患者的预后
7. Monitoring circulating epithelial tumor cells (CETCs) during primary systemic chemotherapy including trastuzumab for early prediction of outcome in patients with Her2/neu-positive tumors [O] . Gajda, M., Camara, O., Oppel, S., 2008

机译：在主要系统化疗期间（包括曲妥珠单抗）监测循环上皮肿瘤细胞（CETC），以早期预测Her2 / neu阳性肿瘤患者的预后

Monitoring circulating epithelial tumour cells (CETC) to gauge therapy: in patients with disease progression after trastuzumab persisting CETC can be eliminated by combined lapatinib treatment

著录项

引文网络

相似文献

相关主题

期刊订阅